Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review

April 2021 | 50 pages | ID: A79980826BCEN
GlobalData

Abstracts

Abeona Therapeutics Inc (ABEO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO-102 adeno-associated virus. Abeona also develops EB-101 for recessive dystrophic epidermolysis bullosa (RDEB), EB-201 for epidermolysis bullosa (EB), ABO-202 (AAV-CLN1) gene therapy for treatment of infantile Batten disease (INCL), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL) and more. The company has partnerships for the commercialization of its products in the US, European Union, Switzerland, Norway, Iceland, Lichtenstein, Australia, New Zealand, China and South Korea. Abeona is headquartered in New York City, the US.

Abeona Therapeutics Inc Key Recent Developments

Mar 25,2021: Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
Mar 24,2021: Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
Mar 22,2021: Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
Feb 22,2021: Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Nov 09,2020: Abeona Therapeutics reports third quarter financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Abeona Therapeutics Inc - Key Facts
Abeona Therapeutics Inc - Key Employees
Abeona Therapeutics Inc - Key Employee Biographies
Abeona Therapeutics Inc - Major Products and Services
Abeona Therapeutics Inc - History
Abeona Therapeutics Inc - Company Statement
Abeona Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Abeona Therapeutics Inc - Business Description
R&D Overview
Abeona Therapeutics Inc - Corporate Strategy
Abeona Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Abeona Therapeutics Inc - Strengths
Abeona Therapeutics Inc - Weaknesses
Abeona Therapeutics Inc - Opportunities
Abeona Therapeutics Inc - Threats
Abeona Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Abeona Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 25, 2021: Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
Mar 24, 2021: Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
Mar 22, 2021: Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
Feb 22, 2021: Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Nov 09, 2020: Abeona Therapeutics reports third quarter financial results
Oct 27, 2020: Abeona Therapeutics announces the appointment of Michael Amoroso as Chief Operating Officer
Oct 06, 2020: Abeona Therapeutics’ Board of Directors forms special committee to oversee operations, develop strategic direction and leadership plan
Sep 28, 2020: Abeona Therapeutics announces leadership and board transitions
Aug 10, 2020: Abeona Therapeutics reports second quarter financial results and business updates
Jul 09, 2020: Abeona Therapeutics announces appointment of Michael Amoroso as Chief Commercial Officer

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Abeona Therapeutics Inc, Key Facts
Abeona Therapeutics Inc, Key Employees
Abeona Therapeutics Inc, Key Employee Biographies
Abeona Therapeutics Inc, Major Products and Services
Abeona Therapeutics Inc, History
Abeona Therapeutics Inc, Subsidiaries
Abeona Therapeutics Inc, Key Competitors
Abeona Therapeutics Inc, Ratios based on current share price
Abeona Therapeutics Inc, Annual Ratios
Abeona Therapeutics Inc, Annual Ratios (Cont...1)
Abeona Therapeutics Inc, Interim Ratios
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Abeona Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Abeona Therapeutics Inc, Performance Chart (2016 - 2020)
Abeona Therapeutics Inc, Ratio Charts
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abeona Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021